CLEVELAND, Ohio -- Lubrizol Life Science Health today announced it has completed a major expansion of its U.S. Medical Device Design Center in Corona, California, to enhance collaboration with customers across the full product lifecycle.
This significant investment adds a dedicated development cell with test lab and pilot lines, including an additional 2,600 square feet of ISO-7 cleanroom space. The expansion also includes additional square footage for future development and manufacturing cleanroom space. To promote collaboration, the expanded site now includes areas accessible to customers who are working with the Lubrizol design team.
The U.S. Medical Device Design Center team is led by Eric Mabry, Senior Manager of Device Design, who brings more than 35 years of experience in medical device design and engineering, including balloon development expertise, to the role. The device design team functions as an extension of customer research and development teams by providing innovative designs of catheters and delivery systems in structural heart, electrophysiology, cardiovascular, neurovascular, and peripheral vascular markets.
Strategically located in the heart of Southern California’s medical device industry, the 53,000 square-foot facility is equipped with test laboratories for device testing and benchmarking, prototyping and development, and cleanrooms for volume production. The U.S. Medical Device Design Center’s capabilities include:
Lubrizol Life Science Health capabilities at the U.S. Medical Device Design Center are complemented by a similar integrated design and development center near Munich, Germany. The full device design team across the U.S. and Europe includes more than 35 engineers and technicians with a combined total of over 425 years of experience and more than 85 patents. There are 110 employees at the U.S. Medical Device Design Center across all phases of design and manufacturing. To learn more about Lubrizol’s device design services and capabilities, visit go.lubrizol.com/MedDeviceDesign.
The Lubrizol Corporation, a Berkshire Hathaway Company, leverages its unmatched science to unlock immense possibilities at the molecular level, driving sustainable and measurable results. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has approximately 8,600 employees. For more information, visit www.Lubrizol.com.
News Categories: <a href=/Newscenter/News-and-Insights?category=Health>Health</a>